Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Secondary market to expand on back of regulatory change says Gamma Finance

Tuesday, November 08, 2011

amb
Florian de Sigy
By Beverly Chandler, Opalesque London:

A probably unintended result of regulatory change designed to improve liquidity and transparency in institutions is driving business into the secondary market, says Florian de Sigy, chief executive officer and founder and Ben Keefe, investment director and head of advisory at Gamma Finance.

Insurance companies will be subject to Solvency II and banks to Basel III, regulatory initiatives designed to limit the potential for a recurrence of the liquidity crisis of a few years ago. Keefe explains: "One of the main tools in the regulators armoury is the ability to charge higher regulatory capital for illiquid assets resulting in a shift in the liquidity profile of the balance sheets of financial institutions. The endgame is that institutions need more liquid transparent assets relative to before. We are seeing a raft of institutions selling off their private equity arms and this is a result of the increasing regulatory capital that the groups would need to support these businesses."

Keefe believes that it is entirely right and proper that these initiatives are being rolled out but has observed an interesting effect that may have a negative impact on the continuing recovery of funds stuck with illiquid assets. "Banks are being required to increase their capital ratio and they can do this by increasing cash or reducing riskier assets" he says. This results in a reduction in lending which impacts directly ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its